Anatomy of a discovery: m1 and m2 macrophages.

Mills CD. · 2015

Read Anatomy of a discovery: m1 and m2 macrophages. by Mills CD. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4419847.txt.

Introduction

Charles Dudley Mills gave a personal account in Frontiers in Immunology in 2015 of how macrophages came to be classed as M1 and M2 types. Macrophages are immune cells that can attack invaders or help repair tissue. Mills traces the experiments and disputes that led him and others to name these two opposed programs.

M1 responses kill microbes and can drive T cells toward attack, while M2 responses repair tissue and favor a different T cell path. Mills argues this flipped an old view: innate immunity, led by macrophages, directs adaptive immunity rather than simply obeying it. The same split, he notes, helps explain outcomes in infection, cancer, autoimmunity, and artery disease.

Catalog record

CREATORMills CD.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4419847

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Anatomy of a Discovery: M1 and M2 Macrophages By Charles Dudley Mills Published in: Frontiers in Immunology DOI: 10.3389/fimmu.2015.00212 ABSTRACT M1 and M2 macrophage-type responses kill or repair in vivo. The unique ability of macrophages to make these polar opposite type of responses provides primary host protection and maintains tissue homeostasis throughout the animal kingdom. In humans and other higher animals, M1 and M2-type macrophage responses also initiate and direct T cells/adaptive immunity to provide additional protection such as Th1 (cytotoxic) or Th2 (antibody-mediated) type responses. Hence, macrophages were renamed M1 and M2 to indicate the central role of macrophages/innate immunity in immune systems. These findings indicate that the long held notion that adaptive immunity controls innate immunity was backward: a sea change in understanding how immune responses occur. The clinical impact of M1/kill and M2/repair responses is immense playing pivotal roles in curing (or causing) many diseases including infections, cancer, autoimmunity, and atherosclerosis. How M1/M2 came to be is an interesting story that, like life, involved Direction, Determination, Discouragement, and Discovery. INTRODUCTION A revolution in immunology is underway. Macrophages and innate immunity are now known to be the primary host defense in all animals (1). It had long been thought that adaptive responses (T and B cells) direct innate immunity (2–6). Immunology had it backward. Why? I am reminded of the humorous phrase: “If you hear the sound of hooves, don’t look for zebras.” That is, look for the obvious (Figure 1). Immunology overlooked animal anatomies. Macrophages were the first “immune” cells to appear in evolution, are present in virtually all tissues, and far outnumber other leukocytes (7–9). Despite these anatomical signposts, most immunologists (from the time of Jenner in the 1700s) have been on a quest for the holy grail of immunology: specificity. One cannot blame them. Specific vaccines have resulted in the elimination of world disease scourges such as smallpox and polio. [Figure: It is useful sometimes to recognize the obvious rather than look for more complicated explanations in science, or in life.] Meanwhile, macrophages were mainly viewed as “trash disposal units” serving at the bequest of the T and B cells and hidden “under the sink” (10). One might say an “Adaptive Dictator” was in charge (9). Macrophages were also an enigma. They displayed the stupefying polar-opposite abilities to inhibit proliferation (e.g., kill pathogens) or to promote proliferation (e.g., repair wounds). How could this be? The kill and repair paradox turned out to be based on the elegantly simple and fascinating ability of macrophages to metabolize arginine to either nitric oxide (NO) or ornithine, respectively (11–17). As important as this discovery was, macrophages held another big secret: one that would fundamentally change our understanding of how immune responses occur. Macrophages’ unique abilities to kill or repair were found in sterile inflammation, where there were no pathogens (foreign antigens), and also in mice without T (or B) cells (14, 16). These observations helped overturn the long-held belief that adaptive responses were necessary to “activate” or “alternatively activate” macrophages (3, 18–20). The importance and independence of innate immunity are highlighted by the oft-overlooked fact that >95% of animals do not have T cells and survive happily in a sea of pathogens, earthworms being an example (7, 8). How? Macrophages! They can kill pathogens within hours. Rapid killing of pathogens is necessary. One bacterium can become the mass of a human in about 4 days, while a T (or B) cell can only become about 16 cells in 4 days. Thus, mathematical considerations alone indicate that clonal proliferation of lymphocytes cannot serve as the primary host defense; this is the job of macrophages throughout the animal kingdom (1). Moreover, in higher animals (e.g., vertebrates) that do have T cells, kill or repair type macrophages (or dendritic cells1) necessarily direct T cells to make Th1 or Th2-type responses, respectively (16, 21–23). Together, these and other results about macrophages have caused a fundamental change in our understanding about how immune systems operate. Macrophages/innate immunity initiates and directs virtually all immune responses, including T and B cells/adaptive immunity (1, 9). Hence, I specifically renamed macrophages M1 and M2 to highlight that they, not T cells, are the core of immune systems (16). Of course, once given innate direction by macrophages, the different types of Th1 or Th2-type responses that result can further elevate (or inhibit) M1- or M2-type macrophage responses (1). The macrophage “revolution” did not happen overnight, and is continuing. But how macrophages came out from “under the sink” to occupy the epicenter of immunology is an interesting story that resembles life itself: one of Direction, Determination, Discouragement, and finally Discovery. It is about the horses, not zebras, of immunology. SETTING A COURSE OF STUDY: CANCER AND IMMUNOLOGY My path to the study of macrophages took awhile. When I entered graduate school in 1974 at the University of Chicago, immunology was pretty new. There was only one immunology course available and few textbooks; so, learning came mainly from reading journals such as the Journal of Immunology or Journal of Experimental Medicine. I came to believe that the next great immunologic triumph would be more specific vaccines. Having drawn blood in a hospital, as an undergraduate at Syracuse University, patients dying of cancer made a profound impression on me. So, immunology and cancer became my focus: my Direction. At this time, cancers appeared to be “foreign” like pathogens (24–26) and viruses were also implicated (27, 28). But, the antigens on cancer cells were weak; they did not readily elicit specific T (or B) cell responses (29). Having decided I wished to study immunology, I joined Robert Hunter’s lab at the University of Chicago because he was investigating why some antigens were more immunogenic (elicit an immune response) than others in hopes of augmenting anti-cancer and other immune responses (30). While thinking about a Ph.D. project, I realized that animal bodies, as a whole, are “negatively charged” (proteins, sugars, cells, etc.). For example, the electrophoretic separation of most proteins is possible because they migrate from the anode (-) to the cathode (+) at different rates. Cells and other molecules must repel, not stick together, in order to move, to flow. Therefore, I proposed that if a protein antigen was modified to be “positively charged,” it would “stick” in the body longer and elicit a stronger immune response as illustrated in Figure 2. It worked (31). [Figure: Injection of bovine serum albumin, chemically modified to be “positively charged,” into a mouse caused it to be retained longer at the site of injection, and stimulated a stronger T cell mediated immune response.] However, not a lot of people were interested in what made antigens immunogenic in the 1970s (recall the Adaptive Dictatorship), and my manuscript to the Journal of Immunology was rejected: a lesson in Discouragement. Along the way, I learned that humor is a useful way to deal with Discouragement. The south side of Chicago was more ethnically “diverse” than where I had lived. The black friends I developed there had the best sense of humor of any group I have encountered. They used humor artfully to diffuse the increased societal Discouragement they typically faced compared to white boys like me. Investigating how the

Read the complete text